154 - NAMPT inhibition is a novel synthetic lethal therapeutic approach exploiting nuclear–mitochondrial crosstalk in ERCC1-deficient populations
| Autor: | Touat, M., Olaussen, K., Sourisseau, T., Friboulet, L., Dorvault, N., Enot, D., Bigot, L., Pontoizeau, C., Mardakheh, F., Thompson, A., Bouillaud, F., Ricchetti, M., Ottolenghi, C., Pierron, G., Sarasin, A., Lombès, A., Ashworth, A., Lord, C., Soria, J.C., Postel-Vinay, S. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S56-S56 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect